Progenics Reports Results of Phase 2/3 Trial of PSMA PET Imaging Agent PyL for the Detection of Prostate Cancer

World News: . []

NEW YORK Oct 05 2018 GLOBE NEWSWIRE -- Progenics Pharmaceuticals Inc NASDAQPGNX an oncology company developing innovative medicines and imaging analysis technology for targeting and treating cancer today announced data from its OSPREY 2301 St...

More news and information about Progenics Pharmaceuticals Inc.

Published By:

Globe Newswire: 12:30 GMT Friday 5th October 2018

Published: .

Search for other references to "progenics" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us